Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.

TUCKER, GA. — The US Poultry & Egg Association (USPOULTRY) and its Foundation announced the completion of a research project that developed messenger ribonucleic acid (mRNA) vaccines for two major ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...